GIBIE Bed and Bath Linens

London, United Kingdom

Short Summary

We are revolutionising the bed & bath linen industry by replacing carcinogenic dyes with skin nourishing herbs. We are doing this by reviving 5000-year-old Ayurvedic dyeing techniques to develop naturally functional bed and bath linens.

Overview

Target
NZ$380,000
Minimum
NZ$1,900
Investment Raised
NZ$38,000
Previous Rounds N/A
Stage Achieving Sales
Investor Role Any

Highlights

  • In talks with several distributors and agents across UK, US and Canada.
  • Amazing initial response on Amazon lead to launch of this brand.
  • Adding new online channels like Wayfair, Houzz in next production.
  • Only brand doing Herbal Bath Linen. Big first mover advantage.
  • Founders have 7 years experience of starting and running a textiles company
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Global Pro
0% raised

Protective Sportswear Ltd.

location_on W. Midlands, United Kingdom

Profitable Sports Co. £1.53m Forecast This Year. Working With UFC Stars Darren Till and Gunner Nelson and England Rugby Player James Haskell. Selling 7-8,000 mouthguards a month. Participants of the GymShark accelerator programme.

NZ$ 470,000

Target

NZ$ 47,000

Min per Investor

20% raised

ZUUS

location_on North West, Afghanistan

ZUUS is an exciting business in the e-commerce cycling sector. We have a track record in growing large cycle related businesses. Ideal for the Government business SIES tax reduction scheme with real prospects of substantial growth.

NZ$ 950,000

Target

NZ$ 47,000

Min per Investor

Featured
19% raised

Inhalable cannabis & CBD

location_on London, United Kingdom

hapac® is a unique patent pending system for vaporising medical cannabis and CBD. It also has the potential to be the lowest-cost cannabis product in the market due to its high-speed automated production and low variable costs.

NZ$ 1,500,000

Target

NZ$ 38,000

Min per Investor

load one similar proposal